Paper8540697
Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
van Etten EW and 3 others. Antimicrob Agents Chemother, 1995. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Papers, record 8540697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8540697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Antifungal Agents | Major topic |
| Candidiasis | Major topic |
| Leukopenia | Major topic |
| Animals | |
| Cyclophosphamide | |
| Drug Carriers | |
| Female | |
| Kidney | |
| Liposomes | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2684010 | Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2684010 | PubMed |
| 2 | 2184499 | Amphotericin B: 30 years of clinical experience. | Rev Infect Dis | 1990 | https://conductscience.org/library/papers/2184499 | PubMed |
| 3 | 2384160 | Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. | FEBS Lett | 1990 | https://conductscience.org/library/papers/2384160 | PubMed |
| 4 | 2223816 | Liposomes for the sustained drug release in vivo. | Biochim Biophys Acta | 1990 | https://conductscience.org/library/papers/2223816 | PubMed |
| 5 | 8515105 | Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. | J Infect Dis | 1993 | https://conductscience.org/library/papers/8515105 | PubMed |
| 6 | 8344999 | Amphotericin B and its delivery by liposomal and lipid formulations. | J Clin Pharm Ther | 1993 | https://conductscience.org/library/papers/8344999 | PubMed |
| 7 | 476012 | Indium-III: a new radionuclide label for studying human platelet kinetics. | Br J Haematol | 1979 | https://conductscience.org/library/papers/476012 | PubMed |
| 8 | 8262869 | Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosis. | J Antimicrob Chemother | 1993 | https://conductscience.org/library/papers/8262869 | PubMed |
| 9 | 8274617 | New methods of delivery of amphotericin B. | Clin Infect Dis | 1993 | https://conductscience.org/library/papers/8274617 | PubMed |
| 10 | 8106769 | Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. | J Infect Dis | 1994 | https://conductscience.org/library/papers/8106769 | PubMed |
| 11 | 8125837 | Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. | J Antimicrob Chemother | 1993 | https://conductscience.org/library/papers/8125837 | PubMed |
| 12 | 8169391 | Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis. | J Infect Dis | 1994 | https://conductscience.org/library/papers/8169391 | PubMed |
| 13 | 8089064 | Clinical use of liposomal and lipid-complexed amphotericin B. | J Antimicrob Chemother | 1994 | https://conductscience.org/library/papers/8089064 | PubMed |
| 14 | 7628985 | Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. | J Antimicrob Chemother | 1995 | https://conductscience.org/library/papers/7628985 | PubMed |
| 15 | 13793161 | The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. | J Biol Chem | 1960 | https://conductscience.org/library/papers/13793161 | PubMed |
| 16 | 2065067 | Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/2065067 | PubMed |
| 17 | 1911826 | Pharmacokinetics of stealth versus conventional liposomes: effect of dose. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/1911826 | PubMed |
| 18 | 1748123 | Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. | Eur J Clin Microbiol Infect Dis | 1991 | https://conductscience.org/library/papers/1748123 | PubMed |
| 19 | 1763060 | Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1763060 | PubMed |
| 20 | 1778892 | Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. | J Antimicrob Chemother | 1991 | https://conductscience.org/library/papers/1778892 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903468 | Challenges posed by fungi to host immunity: Mechanisms of immune evasion. | Hlife | 2026 | https://conductscience.org/library/papers/42903468 | PubMed |
| 42506291 | Bridging the "Valley of Death" in Antifungal Therapy: Next-Generation Biomimetic and Exosome-Inspired Nanocarriers for Invasive Candidiasis. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42506291 | PubMed |
| 41141727 | Long-Circulating Liposomes Codelivering Amphotericin B and Retinoic Acid for Cutaneous Leishmaniasis Treatment. | ACS Omega | 2025 | https://conductscience.org/library/papers/41141727 | PubMed |
| 38459287 | Evaluation of the antifungal properties of nanoliposomes containing rhinacanthin-C isolated from the leaves of Rhinacanthus nasutus. | World J Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/38459287 | PubMed |
| 37859317 | Nanoformulations Insights: A Novel Paradigm for Antifungal Therapies and Future Perspectives. | Curr Drug Deliv | 2024 | https://conductscience.org/library/papers/37859317 | PubMed |
| 34032937 | Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy. | Nanoscale Res Lett | 2021 | https://conductscience.org/library/papers/34032937 | PubMed |
| 33622715 | Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis. | mBio | 2021 | https://conductscience.org/library/papers/33622715 | PubMed |
| 31222254 | Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/31222254 | PubMed |
| 29717819 | Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens. | Adv Healthc Mater | 2018 | https://conductscience.org/library/papers/29717819 | PubMed |
| 28928478 | Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals. | Sci Rep | 2017 | https://conductscience.org/library/papers/28928478 | PubMed |
| 26818726 | Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. | Drugs | 2016 | https://conductscience.org/library/papers/26818726 | PubMed |
| 24379661 | NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/24379661 | PubMed |
| 22544864 | Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. | Pharmacol Rev | 2012 | https://conductscience.org/library/papers/22544864 | PubMed |
| 17722276 | Optimizing efficacy of amphotericin B through nanomodification. | Int J Nanomedicine | 2006 | https://conductscience.org/library/papers/17722276 | PubMed |
| 10817715 | Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10817715 | PubMed |
| 10681315 | Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681315 | PubMed |
| 9736579 | Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9736579 | PubMed |
| 9736577 | Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9736577 | PubMed |
| 9624486 | Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9624486 | PubMed |
| 9449258 | Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9449258 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8540697
GET https://conductscience.org/api/papers/v1/8540697/references?page=2